Correction to: Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice (Cancer Science, (2013), 104, (835-843), 10.1111/cas.12162);Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice

Cancer Science

Volumn 104, Issue 7, 2013, Pages 835-843

  Ito, Kumiko ^a,b   Ishigamori, Rikako ^a   Mutoh, Michihiro ^a   Ohta, Toshihiro ^b   Imai, Toshio ^a   Takahashi, Mami ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI PROTEIN; AGOUTI YELLOW PROTEIN; AZOXYMETHANE; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BETA CATENIN; MESSENGER RNA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE OVEREXPRESSION; GENETIC TRAIT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MACROPHAGE MIGRATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; CELL MOTION; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; COLORECTAL TUMOR; DISEASE MODEL; DRUG EFFECT; GENETICS; HYPERLIPIDEMIA; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MACROPHAGE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; DRUG EFFECTS;

ALLELES; ANIMALS; AZOXYMETHANE; BETA CATENIN; CARCINOGENESIS; CELL MOVEMENT; COCARCINOGENESIS; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; HYPERLIPIDEMIAS; INFLAMMATION; INSULIN; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, INBRED NOD; RNA, MESSENGER; TRIGLYCERIDES;

EID: 84880738905     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.14417     Document Type: Erratum

References (29)

1. AICR. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research, 2007.
2. Otani T, Iwasaki M, Inoue M, Tsugane S. Body mass index, body height, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study. Cancer Causes Control 2005; 16: 839-50.
3. Inoue M, Noda M, Kurahashi N et al. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan (JPHC Study). Eur J Cancer Prev 2009; 18: 240-7.
4. y mice. Int J Cancer 2011; 129: 528-35.
5. Kondo K, Nozawa K, Romida T, Ezaki K. Inbred strains resulting from Japanese mice. Bull Exp Anim 1957; 6: 107-12.
6. Nakamura M, Yamada K. Studies on a diabetic (KK) strain of the mouse. Diabetologia 1967; 3: 212-21.
7. 4 in colon carcinogenesis. Cancer Res 2002; 62: 28-32.
8. Pozharisski KM. Tumours of the intestines. In: Turusov VS, ed. Pathology of Tumours in Laboratory Animals, IARC Scientific Publications no. 1. Lyon: IARC, 1973; 119-40
9. Hata K, Kubota M, Shimizu M et al. Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesis. Carcinogenesis 2012; 33: 702-7.
10. Nagel JM, Staffa J, Renner-Müller I et al. Insulin glargine and NPH insulin increase to a similar degree epithelial cell proliferation and aberrant crypt foci formation in colons of diabetic mice. Horm Cancer 2010; 1: 320-30.
11. Tran TT, Naigamwalla D, Oprescu AI et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutelyenhances colorectal epithelial proliferation in vivo. Endocrinology 2006; 147: 1830-7.
12. Koohestani N, Tran TT, Lee W et al. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer 1997; 29: 69-76.
13. y mice. Asian Pac J Cancer Prev 2012; 13: 4067-73.
14. Siddiqui AA. Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci 2011; 341: 227-31.
15. Herbey II, Ivankova NV, Katkoori VR et al. Colorectal cancer and hypercholesterolemia: review of current research. Exp Oncol 2005; 27: 166-78.
16. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003; 46: 595-607.
17. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004; 95: 475-80.
18. Takayama T, Ohi M, Hayashi T et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001; 121: 599-611.
19. Kukitsu T, Takayama T, Miyanishi K et al. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res 2008; 14: 48-54.
20. Mori H, Hata K, Yamada Y et al. Significance and role of early-lesions in experimental colorectal carcinogenesis. Chem Biol Interact 2005; 155: 1-9.
21. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
22. Araki Y, Okamura S, Hussain SP et al. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 2003; 63: 728-34.
23. He W, Tan R, Dai C et al. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J Biol Chem 2010; 285: 24665-75.
24. Zins K, Abraham D, Sioud M, Aharinejad S. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Cancer Res 2007; 67: 1038-45.
25. Rao G, Wang H, Li B et al. Reciprocal interactions between tumor-associated macrophages and CD44 positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clin Cancer Res 2013; 19: 785-97.
26. Green CE, Liu T, Montel V et al. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS ONE 2009; 8: e6713.
27. 3. Oncogene, 2009; 28: 3892-902.
28. Kaler P, Galea V, Augenlichi L et al. Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1β-dependent stabilization of Snail in tumor cells. PLoS ONE, 2010; 5: e11700.
29. Kang J-C, Chen J-S, Lee C-H et al. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J Surg Oncol, 2010; 102: 242-8.